ProShares UltraPro Nasdaq Biotechnology
Limited financial coverage for UBIO.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
This fund aims to deliver daily returns equal to three times (3x) the daily movement of the NASDAQ Biotechnology Index, prior to accounting for fees and operating costs. To achieve this, it strategically deploys capital into various financial instruments, which ProShare Advisors expects will collectively mirror its ambitious daily performance target. The underlying index itself is a modified capitalization-weighted benchmark, comprising stocks of companies listed on Nasdaq that fall within the biotechnology or pharmaceutical sectors.
- IPO
- 2015
Get TickerSpark's AI analysis on UBIO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $34.80
- 52W Low
- $13.13
- 50D MA
- $17.77
- 200D MA
- $17.77
- Beta
- 3.15
- Avg Volume
- 0
No earnings-call transcripts are available for UBIO yet.
- Free Float
- 0.0%
- Shares Outstanding
- 849.33K
- Float Shares
- 0
Our UBIO coverage
Recent articles, reports, and earnings notes.
No research on UBIO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate UBIO report →